Identifying patients with type 2 diabetes in which basal supported oral therapy may not be the optimal treatment strategy

  • Peter Bramlage, Tobias Bluhmki, Wolfgang Rathmann, Matthias Kaltheuner, Jan Beyersmann, Thomas Danne
  • Diabetes Research and Clinical Practice, June 2016, Elsevier
  • DOI: 10.1016/j.diabres.2016.03.015

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1016/j.diabres.2016.03.015

The following have contributed to this page: Peter Bramlage